Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Staarvisic II Sodium Hyaluronate, 0.8 mL

FDA Recall Z-1106-05 · Posted 2005-08-06

Recalling FirmStaar Surgical Co Inc
Recall StatusTerminated
Product CodeLZP
Date Initiated2005-07-18
Date Terminated2012-07-25
Product Quantity16,464

Reason for Recall

Sterility may be compromised.

Firm Action

Recall will be communicated by telephone, email and letter. A fax back form will be used to track response and to identify ammount on hand.

Root Cause

Other

Distribution Pattern

Nationwide, Canada and Puerto Rico

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑